Health Related Quality of Life and Pain Managment Using Infiltration or Suprascapular Nerve Block Ultrasound Guided in Patients With Glenohumeral Arthirtis
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Pain before
研究概览
简要总结
Efficacy in pain and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in glenohumeral arthritis
详细描述
To describe the efficacy in pain management and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in patients with glenohumeral arthritis
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •IMSS affiliated
- •Glenohumeral arthritis diagnosed
排除标准
- •Previusly treatment for the same disease
- •No follow up
研究组 & 干预措施
Shoulder infiltration
Shoulder infiltration using 2 ml of Lidocaine 2% Injectable Solution and methylprednisolone acetate 40 mg
干预措施: Methylprednisolone Acetate (Drug)
Shoulder infiltration
Shoulder infiltration using 2 ml of Lidocaine 2% Injectable Solution and methylprednisolone acetate 40 mg
干预措施: Lidocaine 2% Injectable Solution (Drug)
Suprascapular nerve block
Suprascapular nerve block ultrasound guided using 25 mg of Ropivacaine HCl Inj 7.5 MG/ML and methylprednisolone acetate 40 mg
干预措施: Methylprednisolone Acetate (Drug)
Suprascapular nerve block
Suprascapular nerve block ultrasound guided using 25 mg of Ropivacaine HCl Inj 7.5 MG/ML and methylprednisolone acetate 40 mg
干预措施: Ropivacaine HCl Inj 7.5 MG/ML (Drug)
结局指标
主要结局
Pain before
时间窗: VAS before intervention
visual analogue scale
Pain 2 months after
时间窗: VAS 2 months after
Visual analogue scale 2 months after procedure
Pain 6 months after
时间窗: VAS 6 months after
Visual analogue scale 6 months after procedure
次要结局
- Quality of life before procedure(SF12v2 before procedure)
- Quality of life 2 months after procedure(SF12v2 2 months after)
- Quality of life 6 months after procedure(SF12v2 6 months after)
研究者
Luis Alonso Calderon Cordova
Principal Investigator
Instituto Mexicano del Seguro Social